191 related articles for article (PubMed ID: 35561739)
1. Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study.
Cardoso R; Guo F; Heisser T; De Schutter H; Van Damme N; Nilbert MC; Tybjerg AJ; Bouvier AM; Bouvier V; Launoy G; Woronoff AS; Cariou M; Robaszkiewicz M; Delafosse P; Poncet F; Walsh PM; Senore C; Rosso S; Lemmens VEPP; Elferink MAG; Tomšič S; Žagar T; Lopez de Munain Marques A; Marcos-Gragera R; Puigdemont M; Galceran J; Carulla M; Sánchez-Gil A; Chirlaque MD; Hoffmeister M; Brenner H
Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):711-723. PubMed ID: 35561739
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study.
Cardoso R; Guo F; Heisser T; Hackl M; Ihle P; De Schutter H; Van Damme N; Valerianova Z; Atanasov T; Májek O; Mužík J; Nilbert MC; Tybjerg AJ; Innos K; Mägi M; Malila N; Bouvier AM; Bouvier V; Launoy G; Woronoff AS; Cariou M; Robaszkiewicz M; Delafosse P; Poncet F; Katalinic A; Walsh PM; Senore C; Rosso S; Vincerževskienė I; Lemmens VEPP; Elferink MAG; Johannesen TB; Kørner H; Pfeffer F; Bento MJ; Rodrigues J; Alves da Costa F; Miranda A; Zadnik V; Žagar T; Lopez de Munain Marques A; Marcos-Gragera R; Puigdemont M; Galceran J; Carulla M; Chirlaque MD; Ballesta M; Sundquist K; Sundquist J; Weber M; Jordan A; Herrmann C; Mousavi M; Ryzhov A; Hoffmeister M; Brenner H
Lancet Oncol; 2021 Jul; 22(7):1002-1013. PubMed ID: 34048685
[TBL] [Abstract][Full Text] [Related]
3. Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries.
Cardoso R; Guo F; Heisser T; De Schutter H; Van Damme N; Nilbert MC; Christensen J; Bouvier AM; Bouvier V; Launoy G; Woronoff AS; Cariou M; Robaszkiewicz M; Delafosse P; Poncet F; Walsh PM; Senore C; Rosso S; Lemmens VEPP; Elferink MAG; Tomšič S; Žagar T; Marques ALM; Marcos-Gragera R; Puigdemont M; Galceran J; Carulla M; Sánchez-Gil A; Chirlaque MD; Hoffmeister M; Brenner H
Lancet Reg Health Eur; 2022 Oct; 21():100458. PubMed ID: 35832063
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and characteristics of faecal immunochemical screen-detected cancers vs non-screen-detected cancers: Results from a Flemish colorectal cancer screening programme.
van de Veerdonk W; Hoeck S; Peeters M; Van Hal G; Francart J; De Brabander I
United European Gastroenterol J; 2020 Mar; 8(2):185-194. PubMed ID: 32213071
[TBL] [Abstract][Full Text] [Related]
5. Interval cancers after negative immunochemical test compared to screen and non-responders' detected cancers in Slovenian colorectal cancer screening programme.
Mlakar DN; Bric TK; Škrjanec AL; Krajc M
Radiol Oncol; 2018 Jul; 52(4):413-421. PubMed ID: 30511936
[TBL] [Abstract][Full Text] [Related]
6. Screening for colorectal cancer in Italy: 2011-2012 survey.
Zorzi M; Mangone L; Anghinoni E; Baracco S; Borciani E; Caldarella A; Falcini F; Fanetti AC; Ferretti S; Giorgi Rossi P; Michiara M; Randi G; Stracci F; Vicentini M; Zucchetto A; Zappa M;
Epidemiol Prev; 2015; 39(3 Suppl 1):108-14. PubMed ID: 26405782
[TBL] [Abstract][Full Text] [Related]
7. Colorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain).
Portillo I; Arana-Arri E; Idigoras I; Bilbao I; Martínez-Indart L; Bujanda L; Gutierrez-Ibarluzea I
World J Gastroenterol; 2017 Apr; 23(15):2731-2742. PubMed ID: 28487610
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
[TBL] [Abstract][Full Text] [Related]
9. Improved 5-year survival of patients with immunochemical faecal blood test-screen-detected colorectal cancer versus non-screening cancers in northern Italy.
Parente F; Vailati C; Boemo C; Bonoldi E; Ardizzoia A; Ilardo A; Tortorella F; Cereda D; Cremaschini M; Moretti R
Dig Liver Dis; 2015 Jan; 47(1):68-72. PubMed ID: 25306524
[TBL] [Abstract][Full Text] [Related]
10. Impact of the bowel-screening programme on the diagnosis of colorectal cancer in Ayrshire and Arran.
Roxburgh CS; McTaggart F; Balsitis M; Diament RH
Colorectal Dis; 2013 Jan; 15(1):34-41. PubMed ID: 22632378
[TBL] [Abstract][Full Text] [Related]
11. Initial Impact of National CRC Screening on Incidence and Advanced Colorectal Cancer.
Krul MF; Elferink MAG; Kok NFM; Dekker E; Lansdorp-Vogelaar I; Meijer GA; Nagtegaal ID; Breekveldt ECH; Ruers TJM; van Leerdam ME; Kuhlmann KFD
Clin Gastroenterol Hepatol; 2023 Mar; 21(3):797-807.e3. PubMed ID: 36116753
[TBL] [Abstract][Full Text] [Related]
12. Screen-detected and interval colorectal cancers in England: Associations with lifestyle and other factors in women in a large UK prospective cohort.
Blanks R; Burón Pust A; Alison R; He E; Barnes I; Patnick J; Reeves GK; Floud S; Beral V; Green J
Int J Cancer; 2019 Aug; 145(3):728-734. PubMed ID: 30694563
[TBL] [Abstract][Full Text] [Related]
13. Colorectal adenocarcinomas diagnosed following a negative faecal immunochemical test show high-risk pathological features in a colon screening programme.
Steel MJ; Bukhari H; Gentile L; Telford J; Schaeffer DF
Histopathology; 2021 Apr; 78(5):710-716. PubMed ID: 33037645
[TBL] [Abstract][Full Text] [Related]
14. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
15. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
16. Postoperative Outcomes of Screen-Detected vs Non-Screen-Detected Colorectal Cancer in the Netherlands.
de Neree Tot Babberich MPM; Vermeer NCA; Wouters MWJM; van Grevenstein WMU; Peeters KCMJ; Dekker E; Tanis PJ;
JAMA Surg; 2018 Dec; 153(12):e183567. PubMed ID: 30285063
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model.
Idigoras I; Arrospide A; Portillo I; Arana-Arri E; Martínez-Indart L; Mar J; de Koning HJ; Lastra R; Soto-Gordoa M; van der Meulen M; Lansdorp-Vogelaar I
BMC Public Health; 2017 Aug; 18(1):78. PubMed ID: 28764731
[TBL] [Abstract][Full Text] [Related]
18. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site.
Steele RJ; McClements P; Watling C; Libby G; Weller D; Brewster DH; Black R; Carey FA; Fraser CG
Gut; 2012 Apr; 61(4):576-81. PubMed ID: 21930729
[TBL] [Abstract][Full Text] [Related]
19. Differences in treatment of stage I colorectal cancers: a population-based study of colorectal cancers detected within and outside of a screening program.
Toes-Zoutendijk E; Breekveldt ECH; van der Schee L; Nagtegaal ID; Elferink MAG; Lansdorp-Vogelaar I; Moons LMG; van Leerdam ME
Endoscopy; 2024 Jan; 56(1):5-13. PubMed ID: 37935373
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer screening programmes and self-reported mammography use in European countries.
Cardoso R; Hoffmeister M; Brenner H
Int J Cancer; 2023 Jun; 152(12):2512-2527. PubMed ID: 36883419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
